Inventor · disambiguated record
Renee M. Zindell
Also filed as: ZINDELL RENEE · ZINDELL RENEE M · ZINDELL RENEE MICHELE
31 granted patents·8 pending applications·425 citations·filing 2003–2018
97Inventor score
Files withBOEHRINGER INGELHEIM INT14BARTOLOZZI ALESSANDRA7BOEHRINGER INGELHEIM PHARMA6BERRY ANGELA3ABEYWARDANE ASITHA2
Top patents by PatentIndex Score
39 records- 0197US7595397B2Compounds which modulate the CB2 receptorBOEHRINGER INGELHEIM INT·Filed 2006·Granted Sep 29, 2009·90 cites·4 claims
- 0295US8048899B2Compounds which selectively modulate the CB2 receptorBOEHRINGER INGELHEIM INT·Filed 2009·Granted Nov 1, 2011·40 cites·32 claims
- 0393US7928123B2Compounds which modulate the CB2 receptorBOEHRINGER INGELHEIM INT·Filed 2007·Granted Apr 19, 2011·32 cites·8 claims
- 0492US8362039B2Therapeutic uses of compounds which selectively modulate the CB2 receptorBOEHRINGER INGELHEIM INT·Filed 2011·Granted Jan 29, 2013·17 cites·20 claims
- 0591US8349871B2Therapeutic uses of compounds which selectively modulate the CB2 receptorBOEHRINGER INGELHEIM INT·Filed 2011·Granted Jan 8, 2013·15 cites·6 claims
- 0691US7189758B2Glucocorticoid mimetics, methods of making them, pharmaceutical formulations, and uses thereofBOEHRINGER INGELHEIM PHARMA·Filed 2005·Granted Mar 13, 2007·19 cites·15 claims
- 0791US6960581B2Glucocorticoid mimetics, methods of making them, pharmaceutical formulations, and uses thereofBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Nov 1, 2005·41 cites·12 claims
- 0890US8940893B2Heteroaromatic compounds as BTK inhibitorsBOSANAC TODD·Filed 2014·Granted Jan 27, 2015·19 cites·10 claims
- 0989US8329735B2Tetrazole compounds which selectively modulate the CB2 receptorERMANN MONIKA·Filed 2011·Granted Dec 11, 2012·26 cites·11 claims
- 1088US8629157B2Pyrrolidine compounds which modulate the CB2 receptorBERRY ANGELA·Filed 2009·Granted Jan 14, 2014·14 cites·10 claims
- 1187US10875852B2Heteroaromatic compounds as BTK inhibitorsBOEHRINGER INGELHEIM INT·Filed 2018·Granted Dec 29, 2020·2 cites·12 claims
- 1287US8546563B2Compounds which modulate the CB2 receptorBERRY ANGELA·Filed 2008·Granted Oct 1, 2013·12 cites·10 claims
- 1386US8372874B2Compounds which selectively modulate the CB2 receptorBOEHRINGER INGELHEIM INT·Filed 2009·Granted Feb 12, 2013·6 cites·12 claims
- 1484US7268152B2Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereofBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Sep 11, 2007·24 cites·11 claims
- 1583US9174980B2Heterocyclic compounds as inhibitors of leukotriene productionBARTOLOZZI ALESSANDRA·Filed 2013·Granted Nov 3, 2015·4 cites·9 claims
- 1682US10138229B2Heteroaromatic compounds as BTK inhibitorsBOEHRINGER INGELHEIM INT·Filed 2017·Granted Nov 27, 2018·2 cites·20 claims
- 1782US8580829B2Oxadiazole inhibitors of leukotriene productionBARTOLOZZI ALESSANDRA·Filed 2011·Granted Nov 12, 2013·8 cites·18 claims
- 1882US8383615B2Azetidine 2-carboxamide derivatives which modulate the CB2 receptorBOEHRINGER INGELHEIM INT·Filed 2010·Granted Feb 26, 2013·6 cites·17 claims
- 1981US8889670B2Heterocyclic compounds which modulate the CB2 receptorBARTOLOZZI ALESSANDRA·Filed 2010·Granted Nov 18, 2014·6 cites·13 claims
- 2081US8829034B2Compounds which modulate the CB2 receptorBERRY ANGELA·Filed 2011·Granted Sep 9, 2014·6 cites·9 claims
- 2180US8946203B2Benzodioxane inhibitors of leukotriene productionABEYWARDANE ASITHA·Filed 2013·Granted Feb 3, 2015·6 cites·16 claims
- 2280US8735430B2Compounds which selectively modulate the CB2 receptorBARTOLOZZI ALESSANDRA·Filed 2012·Granted May 27, 2014·6 cites·13 claims
- 2380US7579469B2Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereofBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Aug 25, 2009·15 cites·8 claims
- 2476US7928103B2Compounds which modulate the CB2 receptorBOEHRINGER INGELHEIM INT·Filed 2007·Granted Apr 19, 2011·2 cites·7 claims
- 2574US8658661B2Oxadiazole inhibitors of leukotriene productionBARTOLOZZI ALESSANDRA·Filed 2011·Granted Feb 25, 2014·3 cites·20 claims
- 2666US8575201B2Oxadiazole inhibitors of leukotriene productionBARTOLOZZI ALESSANDRA·Filed 2011·Granted Nov 5, 2013·1 cites·24 claims
- 2763US8741897B2Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereofBEKKALI YOUNES·Filed 2004·Granted Jun 3, 2014·3 cites·3 claims
- 2860US2014045813A1Heteroaromatic compounds as btk inhibitorsBENTZIEN JOERG MARTIN·Filed 2013·Application pending·0 cites
- 2959US2017320867A1Heteroaromatic compounds as btk inhibitorsBOEHRINGER INGELHEIM INT·Filed 2017·Application pending·0 cites
- 3055US8212040B2Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and thereofBEKKALI YOUNES·Filed 2006·Granted Jul 3, 2012·0 cites·11 claims
- 3154US2016031872A1Heteroaromatic compounds as btk inhibitorsBOEHRINGER INGELHEIM INT·Filed 2015·Application pending·0 cites
- 3251US2009176807A1Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereofREGAN JOHN ROBINSON·Filed 2009·Application pending·0 cites
- 3347US2009275611A1Compounds Which Modulate The CB2 ReceptorBOEHRINGER INGELHEIM INT·Filed 2007·Application pending·0 cites
- 3446US2012015988A1Sulfone Compounds Which Modulate The CB2 ReceptorHICKEY EUGENE RICHARD·Filed 2009·Application pending·0 cites
- 3542US9403830B2Inhibitors of leukotriene productionABEYWARDANE ASITHA·Filed 2013·Granted Aug 2, 2016·0 cites·15 claims
- 3642US2005234091A1Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereofBOEHRINGER INGELHEIM PHARMA·Filed 2005·Application pending·0 cites
- 3739US8580825B2Oxadiazole inhibitors of leukotriene productionBARTOLOZZI ALESSANDRA·Filed 2011·Granted Nov 12, 2013·0 cites·16 claims
- 3839US2005209284A1Tec kinase inhibitorsBOEHRINGER INGELHEIM PHARMA·Filed 2005·Application pending·0 cites
- 3935US8383651B2Compounds which selectively modulate the CB2 receptorBOEHRINGER INGELHEIM INT·Filed 2010·Granted Feb 26, 2013·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Renee M. Zindell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →